Skip to main navigation Skip to search Skip to main content

The origin and development of nonlymphoid tissue CD103+ DCs

  • Florent Ginhoux
  • , Kang Liu
  • , Julie Helft
  • , Milena Bogunovic
  • , Melanie Greter
  • , Daigo Hashimoto
  • , Jeremy Price
  • , Na Yin
  • , Jonathan Bromberg
  • , Sergio A. Lira
  • , E. Richard Stanley
  • , Michel Nussenzweig
  • , Miriam Merad

Research output: Contribution to journalArticlepeer-review

Abstract

CD103+ dendritic cells (DCs) in nonlymphoid tissues are specialized in the cross-presentation of cell-associated antigens. However, little is known about the mechanisms that regulate the development of these cells. We show that two populations of CD11c+MHCII+ cells separated on the basis of CD103 and CD11b expression coexist in most nonlymphoid tissues with the exception of the lamina propria. CD103+ DCs are related to lymphoid organ CD8+ DCs in that they are derived exclusively from pre-DCs under the control of fms-like tyrosine kinase 3 (Flt3) ligand, inhibitor of DNA protein 2 (Id2), and IFN regulatory protein 8 (IRF8). In contrast, lamina propria CD103+ DCs express CD11b and develop independently of Id2 and IRF8. The other population of CD11c +MHCII+ cells in tissues, which is CD103-CD11b +, is heterogenous and depends on both Flt3 and MCSF-R. Our results reveal that nonlymphoid tissue CD103+ DCs and lymphoid organ CD8 + DCs derive from the same precursor and follow a related differentiation program.

Original languageEnglish (US)
Pages (from-to)3115-3130
Number of pages16
JournalJournal of Experimental Medicine
Volume206
Issue number13
DOIs
StatePublished - Dec 21 2009

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'The origin and development of nonlymphoid tissue CD103+ DCs'. Together they form a unique fingerprint.

Cite this